Zobrazeno 1 - 10
of 26
pro vyhledávání: '"C Van Denderen"'
Autor:
J. W. Bolt, C. Aalbers, L. H. Walet, L. Van Mens, J. C. Van Denderen, I. Van der Horst-Bruinsma, L. Van Baarsen, R. B. M. Landewé, M. G. H. Van de Sande
Publikováno v:
Annals of the Rheumatic Diseases. 81:400-401
BackgroundSeveral guidelines advise treating axial spondyloarthritis (axSpA) patients according to the ‘treat-to-target principles’ (T2T)1 although a clear target has not yet been defined. Disease activity measures, which are often used as target
Autor:
M M Ter Wee, T. Rusman, C. van Denderen, S.E. Hoekstra, Michael T Nurmohamed, R. F. van Vollenhoven, I E van der Horst-Bruinsma, Maarten Boers
Publikováno v:
Rusman, T, Nurmohamed, M T, Hoekstra, S, van Denderen, C J, van Vollenhoven, R F, Boers, M, Ter Wee, M M & van der Horst-Bruinsma, I E 2021, ' Disease activity in women with ankylosing spondylitis remains higher under Tumour Necrosis Factor inhibitor treatment than in men : a five-year observational study ', Scandinavian Journal of Rheumatology . https://doi.org/10.1080/03009742.2021.1967046
Scandinavian Journal of Rheumatology, 51, 6, pp. 506-512
Scandinavian Journal of Rheumatology, 51, 506-512
Scandinavian journal of rheumatology. Informa Healthcare
Scandinavian Journal of Rheumatology. Informa Healthcare
Scandinavian Journal of Rheumatology, 51, 6, pp. 506-512
Scandinavian Journal of Rheumatology, 51, 506-512
Scandinavian journal of rheumatology. Informa Healthcare
Scandinavian Journal of Rheumatology. Informa Healthcare
Contains fulltext : 287604.pdf (Publisher’s version ) (Open Access) OBJECTIVE: To assess sex differences in response, level of disease activity, and drug survival in tumour necrosis factor inhibitor (TNFi)-naïve ankylosing spondylitis (AS) patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9788d53daff685843ec0b08b3bca3e4b
https://research.vumc.nl/en/publications/13b76a5e-bf90-41a4-8fe9-89be6679afc2
https://research.vumc.nl/en/publications/13b76a5e-bf90-41a4-8fe9-89be6679afc2
Autor:
J. De Jongh, N. Pouw-Verweij, G. C. J. Zwezerijnen, J. C. Van Denderen, I. Van der Horst-Bruinsma, J. Bot, B. J. H. Boden, R. Hemke, F. F. Smithuis, A. Voskuyl, M. Boers, M. Yaqub, C. J. Van der Laken
Publikováno v:
Annals of the Rheumatic Diseases. 81:793.1-793
BackgroundBone formation is a histopathologic feature of ankylosing spondylitis (AS), causing structural changes through the formation of syndesmophytes and spinal ankyloses (1, 2) Recent studies with [18F]Fluoride Positron emission tomography (PET)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
K. Beek, M. van der Weijden, T. Rusman, W. Lems, C. van Denderen, M. Nurmohamed, I. van der Horst-Bruinsma
Publikováno v:
Saturday, 16 JUNE 2018.
Autor:
I.M. Visman, C. van Denderen, Michael T. Nurmohamed, I.A. Swart, Maaike Heslinga, I E van der Horst-Bruinsma
Publikováno v:
Spondyloarthritis – treatment.
Background Impaired renal function is common in patients with ankylosing spondylitis (AS) and patients also have an increased risk of cardiovascular disease (CVD). Previous studies showed that biologicals, such as anti-Tumour Necrosis Factor (anti-TN
Autor:
I E van der Horst-Bruinsma, Michael T. Nurmohamed, Tamara Rusman, J. C. van Denderen, I.M. Visman
Publikováno v:
Poster Presentations.
Background Limited data are available on the influence of gender and lifestyle factors, such as smoking, alcohol consumption and Body Mass Index (BMI) on disease activity and response to TNF inhibitors (TNFi) in ankylosing spondylitis (AS). Objective
Autor:
C. van Denderen, I E van der Horst-Bruinsma, K. Beek, M.A.C. van der Weijden, Michael T. Nurmohamed, Willem F. Lems
Publikováno v:
Poster Presentations.
Background Ankylosing Spondylitis (AS) is not only characterised by pathological bone formation leading to ankylosis, but also by bone loss which may lead to vertebral fractures (VFx). TNF-alpha inhibitors (TNFi) have proven to be effective in blocki
Autor:
S Bruijnen, N Verweij, L van Duivenvoorde, N Bravenboer, D Baeten, C van Denderen, I der Horst-Bruinsma van, A Voskuyl, P van de Ven, J Bot, B Boden, A Lammertsma, O Hoekstra, P Raijmakers, C van der Laken
Publikováno v:
Bruijnen, S, Verweij, N, Duivenvoorde, L V, Bravenboer, N, Baeten, D, Denderen, C V, van, I D H-B, Voskuyl, A, Ven, P V D, Bot, J, Boden, B, Lammertsma, A, Hoekstra, O, Raijmakers, P & Laken, C V D 2017, ' FRI0623 [18F]fluoride PET-CT imaging of bone formation in ankylosing spondylitis before and after 12 weeks of ANTI-TNF treatment ' . https://doi.org/10.1136/annrheumdis-2017-eular.2004
Background Excessive bone formation is an important hallmark of ankylosing spondylitis (AS). Recently, it has been demonstrated that axial bony lesions in AS patients can be visualized using [ 18 F]fluoride PET-CT. This technique may also provide opp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66ebc48552111b2e218f43e9270b64e3
https://research.vumc.nl/en/publications/5e84632b-0df8-40c5-9b65-f65c32a000a8
https://research.vumc.nl/en/publications/5e84632b-0df8-40c5-9b65-f65c32a000a8
Autor:
J. Ruwaard, E. Kneepkens, C. van Denderen, Theo Rispens, I E van der Horst-Bruinsma, James Cheng-Chung Wei, AF Marsman, Michael T. Nurmohamed, G.J. Wolbink
Publikováno v:
Scandinavian journal of rheumatology, 45(4), 331-334. Informa Healthcare
Marsman, A F, Kneepkens, E L, Ruwaard, J, Wei, J C, Nurmohamed, M T, van Denderen, C, van der Horst-Bruinsma, I E, Rispens, T & Wolbink, G 2016, ' Search for a concentration-effect curve of adalimumab in ankylosing spondylitis patients ', Scandinavian Journal of Rheumatology, vol. 45, no. 4, pp. 331-334 . https://doi.org/10.3109/03009742.2015.1114666
Scandinavian Journal of Rheumatology, 45(4), 331-334. Informa Healthcare
Marsman, A F, Kneepkens, E L, Ruwaard, J, Wei, J C, Nurmohamed, M T, van Denderen, C, van der Horst-Bruinsma, I E, Rispens, T & Wolbink, G 2016, ' Search for a concentration-effect curve of adalimumab in ankylosing spondylitis patients ', Scandinavian Journal of Rheumatology, vol. 45, no. 4, pp. 331-334 . https://doi.org/10.3109/03009742.2015.1114666
Scandinavian Journal of Rheumatology, 45(4), 331-334. Informa Healthcare
The immunogenicity of adalimumab is associated with decreased drug levels, resulting in loss of clinical response in rheumatoid arthritis (RA), psoriatic arthritis (PsA), psoriasis, and ankylosing ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::979d9d4a609f70c59939adc0249c86d8
https://pure.amc.nl/en/publications/search-for-a-concentrationeffect-curve-of-adalimumab-in-ankylosing-spondylitis-patients(f7f1899f-e6a4-4145-bbee-b937cbdd8fd2).html
https://pure.amc.nl/en/publications/search-for-a-concentrationeffect-curve-of-adalimumab-in-ankylosing-spondylitis-patients(f7f1899f-e6a4-4145-bbee-b937cbdd8fd2).html